Cite
Olewicz-Gawlik A, Ginter-Matuszewska B, Kamiński M, et al. Changes in Inflammatory Markers after Administration of Tocilizumab in COVID-19: A Single-Center Retrospective Study. J Clin Med. 2021;11(1)doi: 10.3390/jcm11010107.
Olewicz-Gawlik, A., Ginter-Matuszewska, B., Kamiński, M., Adamek, A., Bura, M., Mozer-Lisewska, I., & Kowala-Piaskowska, A. (2021). Changes in Inflammatory Markers after Administration of Tocilizumab in COVID-19: A Single-Center Retrospective Study. Journal of clinical medicine, 11(1), . https://doi.org/10.3390/jcm11010107
Olewicz-Gawlik, Anna, et al. "Changes in Inflammatory Markers after Administration of Tocilizumab in COVID-19: A Single-Center Retrospective Study." Journal of clinical medicine vol. 11,1 (2021). doi: https://doi.org/10.3390/jcm11010107
Olewicz-Gawlik A, Ginter-Matuszewska B, Kamiński M, Adamek A, Bura M, Mozer-Lisewska I, Kowala-Piaskowska A. Changes in Inflammatory Markers after Administration of Tocilizumab in COVID-19: A Single-Center Retrospective Study. J Clin Med. 2021 Dec 25;11(1). doi: 10.3390/jcm11010107. PMID: 35011848.
Copy
Download .nbib